Copyright
©The Author(s) 2023.
World J Methodol. Sep 20, 2023; 13(4): 323-336
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.323
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.323
Table 1 Baseline demographics of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 study cohorts
Ref. | [22] | [23] | [24] | [25] | [26] | Aggregate | % |
Female | 236 | 174 | 16177 | 104 | 71 | 16762 | 61.21% |
Male | 294 | 190 | 9940 | 85 | 112 | 10621 | 38.79% |
Mean age (SD), year | 59.2 | 61.0 | 51.6 | 50.0 | 57.0 | 54.3 | - |
African American | 62 | 76 | 2551 | 20 | 16 | 2725 | 9.97% |
European American | 155 | 74 | 17752 | 148 | 99 | 18228 | 66.54% |
Asian American | 79 | 6 | 704 | 14 | 16 | 819 | 3.00% |
Hispanic | 132 | 0 | 0 | 0 | 0 | 132 | 0.48% |
Unknown | 102 | 208 | 5110 | 7 | 52 | 5479 | 19.98% |
Table 2 Gastrointestinal and neurological post-acute sequelae of severe acute respiratory syndrome coronavirus 2 symptoms
Symptom | Number of studies | Minimum number | Maximum number | Total of 5 studies |
Anxiety | 2 | 11 | 6738 | 6749 |
Depression | 3 | 6 | 6268 | 6292 |
Dysphagia | 2 | 3 | 6111 | 6114 |
Headache | 5 | 6 | 5223 | 5295 |
Nausea and/or vomiting | 3 | 3 | 5197 | 5223 |
Myalgia | 4 | 11 | 4962 | 5076 |
Gastroesophageal reflux | 1 | 4858 | 4858 | 4858 |
Fatigue | 5 | 29 | 3839 | 4038 |
Abdominal pain | 3 | 2 | 3682 | 3718 |
Dizziness or vertigo | 2 | 7 | 3656 | 3663 |
Constipation | 2 | 8 | 3108 | 3116 |
Stress | 1 | 2925 | 2925 | 2925 |
Neuropathy | 2 | 27 | 2794 | 2821 |
Paresthesia | 2 | 2 | 2794 | 2796 |
Diarrhea | 4 | 2 | 2690 | 2711 |
Abnormal gait | 2 | 18 | 1540 | 1558 |
Brain fog | 5 | 16 | 1410 | 1489 |
Smell & taste problems | 4 | 8 | 1305 | 1356 |
General GI | 1 | 1280 | 1280 | 1280 |
Anorexia | 2 | 5 | 1254 | 1259 |
Dyspepsia | 1 | 5 | 5 | 5 |
Table 3 Gastrointestinal post-acute sequelae of severe acute respiratory syndrome coronavirus 2 symptoms
Symptom1 | Number of studies | Minimum number | Maximum number | Total of 5 studies |
Dysphagia | 2 | 3 | 6111 | 6114 |
Nausea and/or vomiting | 3 | 3 | 5197 | 5223 |
Gastroesophageal reflux | 1 | 4858 | 4858 | 4858 |
Abdominal pain | 3 | 2 | 3682 | 3718 |
Constipation | 2 | 8 | 3108 | 3116 |
Diarrhea | 4 | 2 | 2690 | 2711 |
General GI | 1 | 1280 | 1280 | 1280 |
Anorexia | 2 | 5 | 1254 | 1259 |
Dyspepsia | 1 | 5 | 5 | 5 |
Table 4 Neurological post-acute sequelae of severe acute respiratory syndrome coronavirus 2 symptoms
Symptom1 | Number of studies | Minimum number | Maximum number | Total of 5 studies |
Anxiety | 2 | 11 | 6738 | 6749 |
Depression | 3 | 6 | 6268 | 6292 |
Headache | 5 | 6 | 5223 | 5295 |
Myalgia | 4 | 11 | 4962 | 5076 |
Fatigue | 5 | 29 | 3839 | 4038 |
Dizziness or vertigo | 2 | 7 | 3656 | 3663 |
Stress | 1 | 2925 | 2925 | 2925 |
Neuropathy | 2 | 27 | 2794 | 2821 |
Paresthesia | 2 | 2 | 2794 | 2796 |
Abnormal gait | 2 | 18 | 1540 | 1558 |
Fever | 3 | 2 | 1463 | 1478 |
Brain fog | 5 | 16 | 1410 | 1489 |
Smell & taste problems | 4 | 8 | 1305 | 1356 |
Table 5 Comorbidities in post-acute sequelae of severe acute respiratory syndrome coronavirus 2 patients
Ref.1 | [22] | [23] | [25] | [26] | Aggregate sum |
Total (n) | 530 | 364 | 189 | 183 | 1266 |
Hypertension | 266 | 225 | 39 | 87 | 617 |
Diabetes | 146 | 134 | 11 | 52 | 343 |
Obesity | 158 | - | 72 | 90 | 320 |
Asthma | 55 | 74 | 24 | 19 | 172 |
Hyperlipidemia | - | 125 | - | 20 | 145 |
CAD | 52 | 41 | 3 | 21 | 117 |
Heart failure | 23 | 41 | - | 5 | 69 |
Anxiety disorder | - | - | 54 | - | 54 |
Mood disorder | - | - | 43 | 8 | 51 |
CVA | 28 | 21 | - | - | 49 |
Cancer | 15 | 32 | - | - | 47 |
Chronic kidney disease | - | 29 | - | - | 29 |
Smoking | 18 | - | 9 | - | 27 |
COPD | 19 | - | - | 7 | 26 |
Other | - | - | 15 | - | 15 |
HIV | 10 | - | 4 | - | 14 |
Atrial fibrillation | - | - | 2 | 9 | 11 |
Valvular heart disease | - | - | 3 | - | 3 |
Table 6 Other general symptoms associated with post-acute sequelae of severe acute respiratory syndrome coronavirus 2
Ref. | [22] | [23] | [24] | [25] | [26] | Aggregate sum |
Total number | 530 | 364 | 26117 | 189 | 183 | 27383 |
Weight gain | - | - | 11256 | - | - | 11256 |
Dyspnea | 55 | 58 | 5432 | 35 | 58 | 5638 |
Joint pain | - | - | 5484 | 6 | 29 | 5519 |
Cough | 10 | 37 | 4570 | - | 46 | 4663 |
Chills | - | - | 3839 | - | - | 3839 |
Edema | - | - | 3839 | - | - | 3839 |
Bleeding | - | - | 3708 | - | - | 3708 |
Tachycardia | - | - | 3264 | 16 | - | 3280 |
Pain | - | - | 3212 | - | - | 3212 |
Wheezing | - | - | 3108 | - | - | 3108 |
High BP | - | - | 3108 | - | - | 3108 |
Skin lesion | - | - | 2977 | - | - | 2977 |
Sleep disturbances | - | - | 2925 | 17 | - | 2942 |
Swelling | - | - | 2742 | - | - | 2742 |
Chest pain | 7 | 30 | 2690 | 10 | - | 2737 |
Rash | - | - | 2455 | - | - | 2455 |
Erythema | - | - | 2403 | - | - | 2403 |
Urinary tract symptoms | - | - | 2272 | - | - | 2272 |
Weakness | - | 34 | 2167 | 1 | - | 2202 |
Peripheral edema | - | 22 | 2063 | - | - | 2085 |
Weight loss | - | - | 1906 | - | - | 1906 |
Erectile dysfunction | - | - | 1854 | - | - | 1854 |
Sinonasal congestion | - | - | 1671 | - | - | 1671 |
Respiratory distress | - | - | 1515 | - | - | 1515 |
Sleep apnea | - | - | 1410 | - | - | 1410 |
Throat pain | - | - | - | 11 | - | 11 |
Tinnitus | - | - | 5.2 | - | - | 5.2 |
Nasal congestion | - | - | - | 3 | - | 3 |
Hearing loss | - | - | - | 2 | - | 2 |
Sore throat | - | - | - | - | - | 0 |
Alopecia | - | - | - | - | - | 0 |
- Citation: Sherif ZA, Deverapalli M, Challa SR, Martirosyan Z, Whitesell P, Pizuorno AM, Naqvi Z, Tulloch IK, Oskrochi G, Brim H, Ashktorab H. Potential long-term neurological and gastrointestinal effects of COVID-19: A review of adult cohorts. World J Methodol 2023; 13(4): 323-336
- URL: https://www.wjgnet.com/2222-0682/full/v13/i4/323.htm
- DOI: https://dx.doi.org/10.5662/wjm.v13.i4.323